InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Akamine Scott. Director active across 1 company, notably Cerevel Therapeutics Holdings, Inc.. Aggregated, 5 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €392k. History available since 8 August 2022. The latest transaction was filed on 5 December 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Akamine Scott is a declarant linked to Cerevel Therapeutics Holdings, Inc., where he is Chief Legal Officer. Across the 5 filings recorded, all 5 are in the recent sample, which covers the period from 2022-08-09 to 2024-08-05, with 0 in buys and 392249 in sells, and the modal transaction nature is Exercise of options.